Key result
VA-ECMO enables full recovery in pediatric COVID-19 fulminant myocarditis with cardiogenic shock.
Why the study?
Emerging data suggest an association between SARS-CoV-2 and acute myocarditis, with children being at risk, but detailed clinical courses are limited.
Case Report (n=1)
Suggests VA-ECMO feasibility in pediatric COVID-19 myocarditis; hypothesis-generating and requires prospective validation.
Emerging data suggest an association between severe acute respiratory syndrome coronavirus 2 and the development of acute myocarditis, with children and older adults being most at risk. We describe the clinical course of a previously healthy 12-year-old female who rapidly deteriorated into cardiogenic shock and arrest due to coronavirus disease 2019 induced fulminant myocarditis, necessitating venous-arterial extracorporeal membrane oxygenation as a bridge to full recovery. This case highlights the importance of early clinical recognition of myocardial involvement, and the benefits of taking a multidisciplinary approach in treating these patients.
No takes yet. Share an insight, caveat, or question.
Buitrago et al. (2022) conducted a case report in COVID-19 induced fulminant myocarditis (n=1). Venous-arterial extracorporeal membrane oxygenation (VA-ECMO) was evaluated on Clinical recovery. Venous-arterial extracorporeal membrane oxygenation successfully served as a bridge to full recovery in a 12-year-old female with COVID-19 induced fulminant myocarditis and cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: